tm logo
DEMTEGE
Live/Pending
FOURTH EXTENSION - GRANTED

granted

on 15 Aug 2024

Last Applicant/ Owned by

400 Interpace Parkway

Parsippany

NJ

07054

Serial Number

97110330 filed on 05th Nov 2021

Registration Number

N/A

Correspondent Address

Laurence Rickles

Laurence Rickles TEVA PHARMACEUTICALS USA, INC.

BUILDING A

PARSIPPANY, NJ 07054

United States

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

DEMTEGE

Pharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system, dermatological, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, musculo-skeletal, neurological, opthalmological, pain, renal, metabolic, respiratory, urogenital, urological and viral diseases and disorders; pharmac Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of alimentary, anti-parasitic, autoimmune, blood-related, cancer, cardiovascular, central nervous system, dermatological, endocrine, gastrointestinal, immunological, infectious, inflammatory, menopausal, musculo-skeletal, neurological, opthalmological, pain, renal, metabolic, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for use in hematology


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97110330

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
15th Aug 2024SOU EXTENSION 4 GRANTED
15th Aug 2024SOU EXTENSION 4 FILED
15th Aug 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
15th Aug 2024SOU TEAS EXTENSION RECEIVED
21st Feb 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
20th Feb 2024SOU EXTENSION 3 GRANTED
20th Feb 2024SOU TEAS EXTENSION RECEIVED
20th Feb 2024SOU EXTENSION 3 FILED
18th Aug 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16th Aug 2023SOU EXTENSION 2 GRANTED